miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer

miRNA551b-3p激活抑癌素信号模块,促进三阴性乳腺癌的进展

阅读:9
作者:Deepak Parashar ,Anjali Geethadevi ,Miriam Ragle Aure ,Jyotsna Mishra ,Jasmine George ,Changliang Chen ,Manoj K Mishra ,Andliena Tahiri ,Wei Zhao ,Bindu Nair ,Yiling Lu ,Lingegowda S Mangala ,Cristian Rodriguez-Aguayo ,Gabriel Lopez-Berestein ,Amadou K S Camara ,Mingyu Liang ,Janet S Rader ,Ramani Ramchandran ,Ming You ,Anil K Sood ,Vessela N Kristensen ,Gordon B Mills ,Sunila Pradeep ,Pradeep Chaluvally-Raghavan

Abstract

Genomic amplification of 3q26.2 locus leads to the increased expression of microRNA 551b-3p (miR551b-3p) in triple-negative breast cancer (TNBC). Our results demonstrate that miR551b-3p translocates to the nucleus with the aid of importin-8 (IPO8) and activates STAT3 transcription. As a consequence, miR551b upregulates the expression of oncostatin M receptor (OSMR) and interleukin-31 receptor-α (IL-31RA) as well as their ligands OSM and IL-31 through STAT3 transcription. We defined this set of genes induced by miR551b-3p as the "oncostatin signaling module," which provides oncogenic addictions in cancer cells. Notably, OSM is highly expressed in TNBC, and the elevated expression of OSM associates with poor outcome in estrogen-receptor-negative breast cancer patients. Conversely, targeting miR551b with anti-miR551b-3p reduced the expression of the OSM signaling module and reduced tumor growth, as well as migration and invasion of breast cancer cells.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。